Heart Test Laboratories, Inc. (NASDAQ:HSCS) Sees Large Growth in Short Interest

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 31,200 shares, an increase of 6.1% from the December 15th total of 29,400 shares. Currently, 3.8% of the company’s stock are short sold. Based on an average daily volume of 42,900 shares, the days-to-cover ratio is presently 0.7 days.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on HSCS. Ascendiant Capital Markets reaffirmed a “buy” rating and issued a $15.00 price target on shares of Heart Test Laboratories in a research report on Monday, September 23rd. Maxim Group reaffirmed a “buy” rating and issued a $12.00 target price on shares of Heart Test Laboratories in a report on Wednesday, December 18th.

Heart Test Laboratories Price Performance

Shares of NASDAQ:HSCS opened at $3.47 on Monday. The firm’s 50 day moving average price is $3.42 and its 200-day moving average price is $3.52. The company has a quick ratio of 1.52, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $3.40 million, a PE ratio of -0.44 and a beta of 2.90. Heart Test Laboratories has a twelve month low of $2.36 and a twelve month high of $18.50.

Heart Test Laboratories (NASDAQ:HSCS) last released its earnings results on Monday, December 16th. The company reported ($2.27) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.30) by $0.03. During the same quarter in the previous year, the business earned ($15.92) earnings per share. Equities research analysts expect that Heart Test Laboratories will post -9.82 EPS for the current year.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.